157 related articles for article (PubMed ID: 16404221)
21. Significance of PET/CT in determining actual TNM staging for patients with various lung cancers.
Chiba K; Isoda M; Chiba M; Kanematsu T; Eguchi S
Int Surg; 2010; 95(3):197-204. PubMed ID: 21066996
[TBL] [Abstract][Full Text] [Related]
22. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
Gámez-Cenzano C; Pino-Sorroche F
PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
[TBL] [Abstract][Full Text] [Related]
23. The promise of immuno-PET in radioimmunotherapy.
Verel I; Visser GW; van Dongen GA
J Nucl Med; 2005 Jan; 46 Suppl 1():164S-71S. PubMed ID: 15653665
[TBL] [Abstract][Full Text] [Related]
24. Restaging: should we percist without pattern recognition?
Hofman MS; Hicks RJ
J Nucl Med; 2010 Dec; 51(12):1830-2. PubMed ID: 21078792
[No Abstract] [Full Text] [Related]
25. Radiology and the new TNM classification of tumors: the future.
Sobin LH; Ros PR
Radiology; 1990 Jul; 176(1):1-4. PubMed ID: 2191358
[TBL] [Abstract][Full Text] [Related]
26. [Epidemiological study on PET cancer screening].
Senda M; Inoue T; Uno K; Jinnouchi M; Tsukamoto E; Terauchi T; Nakajima R; Nishizawa S; Minamimoto R; Yoshida T
Kaku Igaku; 2009 Jun; 46(2):100-2. PubMed ID: 19791309
[No Abstract] [Full Text] [Related]
27. Letter from the Editors: low-sensitivity FDG-PET studies.
Freeman LM; Blaufox MD
Semin Nucl Med; 2012 Jul; 42(4):219-20. PubMed ID: 22681670
[No Abstract] [Full Text] [Related]
28. Circulating tumor cells and PET.
Yu JQ; Cristofanilli M
J Nucl Med; 2011 Oct; 52(10):1501-4. PubMed ID: 21911596
[TBL] [Abstract][Full Text] [Related]
29. [Should we improve the TMN 1997 classification?].
Sculier JP
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S111-2. PubMed ID: 10088274
[No Abstract] [Full Text] [Related]
30. The future in diagnosis and staging of lung cancer: positron emission tomography.
Fischer BM; Mortensen J
Respiration; 2006; 73(3):267-76. PubMed ID: 16679747
[TBL] [Abstract][Full Text] [Related]
31. Commonly used imaging techniques for diagnosis and staging.
Barentsz J; Takahashi S; Oyen W; Mus R; De Mulder P; Reznek R; Oudkerk M; Mali W
J Clin Oncol; 2006 Jul; 24(20):3234-44. PubMed ID: 16829647
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography/computed tomography.
Townsend DW
Semin Nucl Med; 2008 May; 38(3):152-66. PubMed ID: 18396176
[TBL] [Abstract][Full Text] [Related]
33. Invasive mediastinal staging is irrelevant for PET/CT positive N2 lung cancer if the primary tumour and ipsilateral lymph nodes are resectable.
Lim E; McElnay PJ; Rocco G; Brunelli A; Massard G; Toker A; Passlick B; Varela G; Weder W
Lancet Respir Med; 2015 Sep; 3(9):e32-e33. PubMed ID: 26380888
[No Abstract] [Full Text] [Related]
34. Letter from the editors.
Freeman LM; Blaufox MD
Semin Nucl Med; 2005 Apr; 35(2):83. PubMed ID: 15765371
[No Abstract] [Full Text] [Related]
35. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
36. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
Kauhanen S; Seppänen M; Ovaska J; Minn H; Bergman J; Korsoff P; Salmela P; Saltevo J; Sane T; Välimäki M; Nuutila P
Endocr Relat Cancer; 2009 Mar; 16(1):255-65. PubMed ID: 19088184
[TBL] [Abstract][Full Text] [Related]
37. [Use of PET for evaluation of treatment response in oncology].
Bourguet P
Cancer Radiother; 2006 Nov; 10(6-7):334-7. PubMed ID: 16950641
[TBL] [Abstract][Full Text] [Related]
38. [Positron emission tomography (PET)--current state of the art and future perspectives].
von Schulthess GK;
Praxis (Bern 1994); 2005 Aug; 94(35):1331-7. PubMed ID: 16171004
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography and colorectal cancer.
Lin M; Wong K; Ng WL; Shon IH; Morgan M
Crit Rev Oncol Hematol; 2011 Jan; 77(1):30-47. PubMed ID: 20619671
[TBL] [Abstract][Full Text] [Related]
40. PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.
Endo K; Oriuchi N; Higuchi T; Iida Y; Hanaoka H; Miyakubo M; Ishikita T; Koyama K
Int J Clin Oncol; 2006 Aug; 11(4):286-96. PubMed ID: 16937302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
